Inventor · disambiguated record
Marcin Tomasz Kortylewski
Also filed as: KORTYLEWSKI MARCIN · KORTYLEWSKI MARCIN TOMASZ
20 granted patents·12 pending applications·62 citations·filing 2005–2025
94Inventor score
Top patents by PatentIndex Score
32 records- 0196US9976147B2STAT3 inhibitors and uses thereofHOPE CITY·Filed 2016·Granted May 22, 2018·13 cites·24 claims
- 0294US11591596B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2020·Granted Feb 28, 2023·3 cites·34 claims
- 0393US12227745B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2023·Granted Feb 18, 2025·1 cites·20 claims
- 0492US11912995B2CTLA-4 aptamer conjugatesHOPE CITY·Filed 2021·Granted Feb 27, 2024·1 cites·17 claims
- 0592US11186840B2CTLA-4 aptamer conjugatesHOPE CITY·Filed 2020·Granted Nov 30, 2021·2 cites·14 claims
- 0692US10801026B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2016·Granted Oct 13, 2020·6 cites·15 claims
- 0789US11801266B2Methods of using anti-MIR126 compoundsHOPE CITY·Filed 2020·Granted Oct 31, 2023·2 cites·14 claims
- 0889US10758624B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2016·Granted Sep 1, 2020·5 cites·20 claims
- 0989US10711272B2CTLA-4 aptamer siRNA speciesHOPE CITY·Filed 2015·Granted Jul 14, 2020·3 cites·16 claims
- 1088US9688982B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2013·Granted Jun 27, 2017·7 cites·4 claims
- 1187US11208654B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2019·Granted Dec 28, 2021·1 cites·16 claims
- 1287US8748405B2Methods and compositions for the treatment of cancer or other diseasesYU HUA·Filed 2011·Granted Jun 10, 2014·7 cites·3 claims
- 1386US10253318B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2017·Granted Apr 9, 2019·3 cites·14 claims
- 1484US9200280B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·4 cites·3 claims
- 1583US2024309379A1Ctla-4 aptamer conjugatesHOPE CITY·Filed 2024·Application pending·0 cites
- 1682US11464865B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2020·Granted Oct 11, 2022·1 cites·20 claims
- 1782US10829765B2STAT3 inhibitors and uses thereofHOPE CITY·Filed 2018·Granted Nov 10, 2020·1 cites·20 claims
- 1880US7951374B2Methods for inhibiting STAT3 signaling in immune cellsUNIV SOUTH FLORIDA·Filed 2005·Granted May 31, 2011·1 cites·14 claims
- 1979US2023193258A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2021·Application pending·0 cites
- 2074US9200279B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·1 cites·4 claims
- 2173US2022401563A1Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 2269US2025207135A1Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2025·Application pending·0 cites
- 2368US2021207142A1Stat3 inhibitors and uses thereofHOPE CITY·Filed 2020·Application pending·0 cites
- 2468US2025248939A1Lipid nanoparticles, nucleic acids, and methods of useHOPE CITY·Filed 2023·Application pending·0 cites
- 2560US2023203085A1Multi-conjugates comprising multiple ligandsMPEG LA L L C·Filed 2022·Application pending·0 cites
- 2659US12472209B2Neural stem cell delivery of therapeutic agentsHOPE CITY·Filed 2020·Granted Nov 18, 2025·0 cites·23 claims
- 2759US2008214436A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2007·Application pending·0 cites
- 2858US2025376689A1Oligonucleotides having 6-thio-2'-deoxyguanosine residues and uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 2956US2023220385A1Microrna as a therapeutic agentHOPE CITY·Filed 2020·Application pending·0 cites
- 3055US12404509B2Oligonucleotide-based proteolysis targeting chimeraHOPE CITY·Filed 2019·Granted Sep 2, 2025·0 cites·20 claims
- 3153US2022002730A1Oligonucleotide inhibitors of nuclear factor kappa-light-chain-enhancer of activated b cells and the uses thereofHOPE CITY·Filed 2019·Application pending·0 cites
- 3236US2011071210A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marcin Tomasz Kortylewski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →